References
- National Cancer Institute [Internet]. Cancer stat facts: chronic lymphocytic leukaemia (CLL). 2017 [cited 2017 Apr]. Available from: http://seer.cancer.gov/statfacts/html/clyl.html
- Australian Government [Internet]. Chronic lymphocytic leukaemia statistics. 2016. [cited 2017 Mar 2]. Available from: http://canceraustralia.gov.au/affected-cancer/cancer-types/leukaemia/chronic-lymphocytic-leukaemia-statistics
- Cancer Research UK [Internet]. Chronic lymphocytic leukaemia (CLL) incidence statistics. 2017 [cited 2017 Apr]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/leukaemia-cll/incidence#heading-Two
- World Health Organisation [Internet]. Skin cancers. 2017 [cited 2017 Apr]. Available from: http://www.who.int/uv/faq/skincancer/en/index1.html.
- Cancer Council Australia [Internet]. Skin cancer incidence and mortality. 2016. [cited 2017 Mar 2]. Available from: http://wiki.cancer.org.au/skincancerstats/Skin_cancer_incidence_and_mortality
- Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options in Oncol. 2004;5:215–223.
- Onajin O, Brewer JD. Skin cancer in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2012;10:571–576.
- Royle JA, Baade PD, Joske D, et al. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer. 2011;105:1076–1081.
- Forsyth CJ, Tiley C, Mulligan SP. Prevelance of melanoma and non-melanoma skin cancer in chronic lymphocytic leukaemia in Australia. Poster session presented at the meeting of the Haematology Society of Australia and New Zealand, the Australian & New Zealand Society of Blood Transfusion and the Thrombosis and Haemostasis Society of Australia and New Zealand, Adelaide, Australia; 2009.
- Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin’s lymphoma and skin cancer. BMJ. 1995;310:1491–1495.
- Mehrany K, Weenig RH, Lee KK, et al. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2005;53:1067–1071.
- Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65:253–261.
- Solomon BM, Chaffee KG, Moreira J, et al. Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis. Leukemia. 2016;30:331–336.
- Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood. 2015;126:454–462.
- Schöllkopf C, Rosendahl D, Rostgaard K, et al. Risk of second cancer after chronic lymphocytic leukemia. Int J Cancer. 2007;121:151–156.
- Hisada M, Biggar RJ, Greene MH, et al. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98:1979.
- Travis LB, Curtis RE, Hankey BF, et al. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992;84:1422–1427.
- McKenna DB, Stockton D, Brewster DH, et al. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer. 2003;88:74–78.
- Levi F, Randimbison L, Te VC, et al. Non-Hodgkin’s lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer. 1996;74:1847–1850.
- Agnew KL, Ruchlemer R, Catovsky D, et al. Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol. 2004;150:1129–1135.
- Robak E, Robak T. Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma. 2007;48:855–865.
- Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatologic Surg. 2004;30:642–650.
- Hofbauer GF, Anliker M, Arnold A, et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly. 2009;139:407–415.
- Chadban SJ, Barraclough KA, Campbell SB, et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO clinical practice guideline for the care of kidney transplant recipients. Nephrology (Carlton). 2012;17:204–214.
- Singh MK, Brewer JD. Current approaches to skin cancer management in organ transplant recipients. Semin Cutan Med Surg. 2011;30:35–47.
- Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10.
- De Hertog SA, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. JCO. 2001;19:231–238.
- Green AC, Williams GM, Logan V, et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. JCO. 2011;29:257–263.
- Wong CC, Liu W, Gies P, et al. Think UV, not heat!. Australas J Dermatol. 2015;56:275–278.
- Australian and New Zealand Bone and Mineral Society, The Australasian College of Dermatologists, Cancer Council Australia, Endocrine Society of Australia, Osteoporosis Australia. Position statement – risks and benefits of sun exposure. 2016. [cited 2017 Apr 21]. Available from: http://wiki.cancer.org.au/policy/Position_statement_-_Risks_and_benefits_of_sun_exposure
- McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol. 1999;140:656–660.
- Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol. 2005;152:518–523.
- George R, Weightman W, Russ GR, et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol. 2002;43:269–273.
- Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–1626.
- Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol. 2013;68:S28–S38.
- Carney DA, Mulligan SP. Chronic lymphocytic leukaemia: current first-line therapy. Intern Med J. 2009;39:44–48.